Mental health professionals’ perspectives on transdiagnostic mobile interventions for Emotional Disorders (EDs) remain underexplored, despite their potential role in integrating ecological interventions into psychological care. This study examined the usability, acceptability, perceived clinical utility, and implementation potential of EmoGuia, a smartphone-based Ecological Momentary Intervention grounded in the Unified Protocol. Using the Consensual Qualitative Research framework, focus groups involving nine therapists and researchers were conducted following a one-week app trial. Thematic findings identified 13 categories across three domains: (1) target population, (2) satisfaction and app experience, and (3) perceived utility. Usability was additionally assessed via the System Usability Scale (SUS). Participants perceived EmoGuia as intuitive, simple, and suitable for young adults with mild-to-moderate anxiety or depressive symptoms. It was perceived as useful for fostering emotional awareness, reinforcing therapeutic content, and preventing dropout. Recommended improvements included personalized feedback, simplified language, and better notification management. SUS scores indicated high perceived usability (M = 79.4; SD = 12.1). These findings support EmoGuia as a promising low-intensity, adjunctive tool for early intervention in EDs and provide implementation-relevant guidance for its iterative refinement. Patient-inclusive longitudinal studies are needed to establish acceptability, engagement, feasibility, and clinical effectiveness.
Introduction: For anxiety disorders (ADs), the preferred treatment is cognitive-behavioural therapy (CBT), with in vivo exposure (IVE) as its main component. IVE aims to gradually expose the patient to feared stimuli and situations to encourage habituation. Despite its effectiveness, it is a hard component for patients, especially when applied on their own. Therefore, a (co-)therapist usually supports the exposure requiring considerable time and resources. Meanwhile, smartphones have become a promising tool to complement and deliver psychological treatments. Methods and analysis: The study presents the protocol of a randomised controlled trial to evaluate the efficacy of an app (SyMptOMS-ET) to support IVE for ADs. The app provides a just-in-time momentary ecological intervention by profiting from advanced smartphone features to monitor, interact and guide the patient through the exposure based on their condition and context. Participants (158) will be adult volunteers suffering from Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) ADs (specific phobia, agoraphobia, panic disorder and social anxiety). They will be randomly allocated to (1) CBT with traditional IVE (79) and (2) CBT with IVE using SyMptOMS-ET (79). The Diagnostic Interview for DSM, Fourth Edition, Text Revision (DSM-IV-TR) ADs will be used as a diagnostic measure. Primary outcome measures will be assessed with interference and fear scales from the Anxiety Disorders Interview Schedule for DSM-IV and with target behaviours; acceptability, satisfaction, usability and app quality will also be measured. Patients will be assessed at baseline, after treatment and at 1-month, 6-month and 12-month follow-ups. Data will be analysed both per-protocol and by intention-to-treat. It will contribute to the knowledge of just-in-time interventions, making the exposure component more accessible to patients. Ethics and dissemination: The Universitat Jaume I Ethics Committee (Castellón, Spain) granted approval for the study (CEISH/51/2024). The results from this study will be actively disseminated through manuscript publications and presentations at national and international conferences. Trial registration number: NCT06788119 .